Find Articles



Return to:Adhd Articles
Or:Recent Adhd Articles

Long-Term 12-Month Safety Data Presented on ADHD Patch Daytrana ...


http://www.pharmalive.com/News/Index.cfm?articleid=487487

Phramalive.com - Study Shows ADHD Patch Provides Tolerable and Effective Symptom Control BOSTON, Oct. 25 /PRNewswire-FirstCall/ -- Shire plc , the global specialty biopharmaceutical company, announced that data from a 12-month study of DAYTRANA(TM) (methylphenidate ...



Article Finder:

October 25, 2007 12:26:00 PM
Article Directory